First-ever International Pharma Convention 2014 will be held on September 16, at Karachi Expo Centre. This International Convention will address on the leading pharmaceutical and compliance issues in the world with a specific perspective to Asia.
Pharma Convention is focusing on the key issues of designing products specifically for people in the lower part of the pyramid, spotting and serving completely new needs, scaling out, not up ie, involving a wider range of people in production and distribution, using mass-market techniques to deliver complex services, making old tools do new tricks using mobile technologies to improve compliance. Going forward, companies are making impressive gains in the growth.
Chief guest Dr Miftah Ismail, Special Assistant to the Prime Minister/Chairman, Board of Investment will address to this convention. Nasir Javed Chowdhry, Chairman PPMA; Haroon Qasim, Managing Director, PharmEvo; Ayub Siddiqui, Sanofi-aventis Pakistan; Salman Burney, GlaxoSmithKline; Zahid Saeed, Indus Pharma; Kaiser Waheed, Medisure; Shahab Rizvi, Novartis Pharma; Saeed Allawala, Atco Laboratories; Kashif Sajjad Sheikh, CCL Pharmaceuticals; Rafael Beaus, Managing Director, Telstar Spain; Jamal Mokaddam, Business Development Director, Romaco Group; Dr Ishrat Hussain, Dean & Director, IBA; Dr Tahir S Shamsi, Medical Director, NIBD will give presentations at the convention.
Globally, the scientific foundation on which the Pharma industry rests has improved vastly over the years. Technologies for collecting and synthesising biological data are improving and becoming much cheaper and more efficient. However, in the short term, the industry continues to face challenges like patent cliff, rising drug discovery cost, harsher regulations and price controls, coupled with spiralling healthcare cost.-PR
Comments
Comments are closed.